Back | Next |
home / stock / hils / hils message board
Subject | By | Source | When |
---|---|---|---|
going up on a/h trading, this board is | gail | investorshub | 04/12/2023 11:49:24 PM |
$HILS Looks pretty positive | gail | investorshub | 04/12/2023 10:08:18 PM |
short data if anyone is interested | Triple nickle | investorshub | 04/12/2023 7:23:48 PM |
$HILS Time for a bounce? | subslover | investorshub | 04/12/2023 6:02:29 PM |
grabbed a few for the squeeze. | gail | investorshub | 04/12/2023 5:34:19 PM |
Price now last up | harry crumb | investorshub | 04/12/2023 3:53:11 PM |
Do we have a winner?Turn around time? | harry crumb | investorshub | 04/12/2023 1:09:22 PM |
must see | PennyPusher786 | investorshub | 04/12/2023 12:07:46 PM |
The gaining last trade up | TheFinalCD | investorshub | 04/12/2023 11:37:22 AM |
$HILS MomentumIts now last trade up | harry crumb | investorshub | 04/12/2023 6:34:42 AM |
$HILS good read | harry crumb | investorshub | 04/12/2023 2:31:41 AM |
Long and strong lets hope im right | harry crumb | investorshub | 04/12/2023 1:38:03 AM |
is it bear time? Or do we go bull? | harry crumb | investorshub | 04/12/2023 12:32:30 AM |
what do you make of this data? | harry crumb | investorshub | 04/11/2023 10:36:58 PM |
$HILS best news of the day | stocks2watch | investorshub | 04/11/2023 10:01:40 PM |
news all the way baby | harry crumb | investorshub | 04/11/2023 7:22:06 PM |
Price now last up | harry crumb | investorshub | 04/11/2023 6:18:20 PM |
Good news recently, we should start to see this one move | Awl416 | investorshub | 04/11/2023 4:23:13 PM |
Found an interesting article | harry crumb | investorshub | 04/11/2023 12:45:02 PM |
Price gaining up | harry crumb | investorshub | 04/11/2023 9:47:46 AM |
News, Short Squeeze, Breakout and More Instantly...
Hillstream BioPharma Inc. Company Name:
HILS Stock Symbol:
NASDAQ Market:
Expects to launch and complete a Phase 1 trial in Q4 2023 Tharimmune to begin trading under new ticker, THAR, on Monday September 25, 2023 BRIDGEWATER, NJ / ACCESSWIRE / September 22, 2023 / Hillstream BioPharma Inc., (NASDAQ:HILS), a biotechnology company developing innovative therapeu...
JUPITER, Fla., Sept. 21, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Dawson James Securities, Inc. (“Dawson”), a full-service investment bank focused on emerging growth companies, today announces its 8 th Annual Dawson James Small Cap Growth Conferen...
Anticipate completion of Phase 1 & Phase 2 clinical trials in chronic pruritis over the next approximately 12 months Seeking first approval in an orphan disease, PBC, for the treatment of moderate to severe chronic pruritis in which more than 70% of patients suffer from chronic prur...